Yang Yang

Yang Yang

Auto-generated profile, based on publicly available information

Yang Yang

Department of Anesthesiology, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, TX, USA

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 March 2022 in Journal of Hepatology
Verified
Journal Article
Closed access
LXLong Xu
Long Xu
YYYang Yang
Yang Yang
Yankai WenYankai Wen
Yankai Wen
JJJong-Min Jeong
Jong-Min Jeong
CEChristoph Emontzpohl
Christoph Emontzpohl
CJCynthia Ju
Cynthia Ju

3 February 2021 in Science Translational Medicine
Verified
Journal Article
Closed access
YWYaochun Wang
Yaochun Wang
YYYang Yang
Yang Yang
MWMeng Wang
Meng Wang
SWshuhong wang
shuhong wang
JJJong-Min Jeong
Jong-Min Jeong
CJCynthia Ju
Cynthia Ju
Eosinophils protect against liver injury during orthotopic liver transplantation and other conditions of hepatic ischemia-reperfusion injury in mice.

9 May 2024 in Gut
Verified
Journal Article
Open access
PDF file
YYYang Yang
Yang Yang
LXLong Xu
Long Xu
CAConstance Atkins
Constance Atkins
LKLily Kuhlman
Lily Kuhlman
JZJie Zhao
Jie Zhao
CJCynthia Ju
Cynthia Ju
Objective Previous studies indicate that eosinophils are recruited into the allograft following orthotopic liver transplantation and protect from ischaemia reperfusion (IR) injury. In the current studies, we aim to explore whether their protective function could outlast during liver repair. Design Eosinophil-deficient mice and adoptive transfer of bone marrow-derived eosinophils (bmEos) were employed to investigate the effects of eosinophils on tissue repair and regeneration after hepatic IR injury. Aside from exogenous cytokine or neutralising antibody treatments, mechanistic studies made use of a panel of mouse models of eosinophil-specific IL-4/IL-13-deletion, cell-specific IL-4rα-deletion in liver macrophages and hepatocytes and macrophage-specific deletion of heparin-binding epidermal growth factor-like growth factor (hb-egf). Result We observed that eosinophils persisted over a week following hepatic IR injury. Their peak accumulation coincided with that of hepatocyte proliferation. Functional studies showed that eosinophil deficiency was associated with a dramatic delay in liver repair, which was normalised by the adoptive transfer of bmEos. Mechanistic studies demonstrated that eosinophil-derived IL-4, but not IL-13, was critically involved in the reparative function of these cells. The data further revealed a selective role of macrophage-dependent IL-4 signalling in liver regeneration. Eosinophil-derived IL-4 stimulated macrophages to produce HB-EGF. Moreover, macrophage-specific hb-egf deletion impaired hepatocyte regeneration after IR injury. Conclusion Together, these studies uncovered an indispensable role of eosinophils in liver repair after acute injury and identified a novel crosstalk between eosinophils and macrophages through the IL-4/HB-EGF axis.

15 July 2022 in Hepatology
Verified
Journal Article
Closed access
LXLong Xu
Long Xu
YYYang Yang
Yang Yang
JJJiali Jiang
Jiali Jiang
Yankai WenYankai Wen
Yankai Wen
JJJong‐Min Jeong
Jong‐Min Jeong
CJCynthia Ju
Cynthia Ju

17 April 2023 in Hepatology
Verified
Journal Article
Closed access
Yankai WenYankai Wen
Yankai Wen
CEChristoph Emontzpohl
Christoph Emontzpohl
LXLong Xu
Long Xu
CAConstance L. Atkins
Constance L. Atkins
JJJong‐Min Jeong
Jong‐Min Jeong
CJCynthia Ju
Cynthia Ju

4 May 2026 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
YYYang Yang
Yang Yang
CAConstance L. Atkins
Constance L. Atkins
YFYuanyuan Fan
Yuanyuan Fan
LHLidan Hou
Lidan Hou
JZJie Zhao
Jie Zhao
CJCynthia Ju
Cynthia Ju
Inflammatory bowel disease (IBD) is driven by a breakdown in immune regulation and epithelial barrier function, yet the contribution of eosinophils to this process has remained poorly defined and controversial. While eosinophils infiltrate the intestinal mucosa during both flares and remission, their role in shaping disease outcomes is unclear. Our RNA-seq analyses of colonic eosinophils isolated from dextran sulfate sodium (DSS)-treated mice revealed a significant upregulation of cyclooxygenase (COX)-2 (gene name, Ptgs2 ). Eosinophil-specific deletion of COX-2 (Ptgs2 fl/fl eoCre +/− ) reduced IL-22 production and exacerbated DSS- and trinitrobenzene sulfonic acid (TNBS)-induced colitis, characterized by greater weight loss, higher disease activity, colon shortening, and epithelial injury. Administration of recombinant IL-22 reversed these phenotypes. Mechanistically, eosinophil-derived COX-2 enhanced IL-22 production by type 3 Innate lymphoid cells (ILC3s) through prostaglandin E2 (PGE 2 ) signaling. Consistently, Ptgs2 fl/fl eoCre +/− mice exhibited reduced colonic PGE 2 levels, while PGE 2 analog treatment restored IL-22 production and mucosal protection. Our findings identify eosinophil-derived COX-2 and PGE 2 as a critical regulator of IL-22 production during colitis, uncovering a eosinophil–ILC3 cross talk that safeguards the intestinal barrier and represents a promising therapeutic target in IBD.